Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-01 23:02:58 - browse：6

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： How artificial intelligence is being used to detect, treat cancer

knowledge

WSS

Amylyx ALS drug failure raises questions and concerns

Death toll from an explosion and collapse of a Paris building in June climbs to 3

NEJM study link tiny plastics in blood vessels to heart problems

CDC marks new Covid

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Air quality improving but still lags in Black, Hispanic communities

hotspot

Wikipedia

focus

Peter Hotez and the public health issue of online harassment

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Tori Bowie and the unacceptable rates of Black maternal death

Russian special forces kill a gunman who broke into a private house near Moscow

Virginia high school admissions case could be legal follow

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Anesthesiologist group: stop taking Ozempic before surgery

FDA official pushes for dedicated emerging pathogens team

Apple is now the first public company to be valued at $3 trillion

CDC marks new Covid

hotspot

Precocious puberty in girls comes with mental health risks

In his State of the Union, Biden takes clear aim at 'Big Pharma'

7 of the most gruesome medical devices in history

Death toll from an explosion and collapse of a Paris building in June climbs to 3

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Death toll from an explosion and collapse of a Paris building in June climbs to 3

knowledge

Wikipedia

knowledge

entertainment